Market intelligence, trend analysis and forecasts for the Pharma and Healthcare industries across the regions

Argentina

Argentina Articles

Companies

Roemmers is the leading drug manufacturer in Argentina, claiming a market share of around 8%. The company was founded in 1921, and employs around 900 people in the home

2006-05-09

Companies

Argentine consumer watchdog CNDC has fined French drug major Sanofi-Aventis ARS0.83mn (US$0.27mn) for failing to notify finance ministry officials of merger plans in 2003. The acquisition... 2006-05-05


Companies

Argentine indigenous drug manufacturers' association CILFA has called on the country's government to improve incentives for the sector. Local firms including market leader Roemmers... 2006-04-28


Companies

Argentine statistics office INDEC estimates that total sales by Argentina's indigenous drug firms grew 5.4% in 2005 at manufacturer prices. Local sources have pointed to further data... 2006-04-20


Companies

Argentine drug regulator ANMAT has published a revision to its drug registration law, No. 3802/04, which will be effective from May 2, 2006. The measure - which was postponed in 2004... 2006-04-18


Companies

Data released by Chilean industry association ASILFA indicates that Uruguay and Venezuela led the Latin American pharmaceutical market in terms of per capita unit sales in 2005. The... 2006-04-11


Companies

Argentine drugmaker Gideon Pharma is to invest some EUR20mn (US$24mn) in Olvega, central Spain, according to government officials. No further details - either relating to the company... 2006-04-05


Companies

Argentina's health minister, Gines Gonzalez Garcia, has claimed that 'the majority' of medicine prices in the country are 'stable'. The official insisted that prices are not breaking... 2006-04-05


Companies

Local press reports claim that Swiss drugmaker Roche is to concede voluntary licences for its supposed avian flu treatment Tamiflu (oseltamivir) in Argentina. According to a company... 2006-04-04


Companies

Leading Argentine drugmaker Roemmers - which claims a 9% share of the country's US$2bn drug market - expects local firms to raise prices in the coming months. The comments come amid... 2006-03-29

31 to 40 of 45 results
<< | < | 1 | 2 | 3 | 4 | 5 | > | >>
Insight